Drug Channels
APRIL 26, 2024
Kevin asks: What if there were no barriers across the therapy access and reimbursement process? Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Today’s guest post comes from Kevin Kettler, President of CoverMyMeds. Meet CoverMyMeds in Booth 1305 at the Asembia AXS24 Summit.
Drug Channels
NOVEMBER 11, 2022
Today’s guest post comes from Lung-I Cheng, Vice President of Cell & Gene Therapy at AmerisourceBergen. Lung-I discusses advancements in cell and gene therapy and explains how to tackle the challenges facing manufacturers, providers, and patients. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
JULY 7, 2023
Sahil discusses how manufacturers can balance patients’ access to therapy with gross-to-net (GTN) goals. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Today’s guest post comes from Sahil Naik, Chief of Staff to the CEO at Phil, Inc. Read on for Sahil’s insights. d/b/a Drug Channels Institute.
Drug Channels
OCTOBER 24, 2024
He then maintains that patients can access new therapies more quickly when the manufacturer relies on a brand-agnostic hub connected to a large network of providers and integrated with the systems those providers use daily. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.
Drug Target Review
FEBRUARY 28, 2024
Over the past 25 years, T-cell therapies have gained significant ground in the treatment of cancer. Preclinical research on γδ T cells has made great strides since the cells were first identified in the 1980s, with γδ T-cell therapies from several companies, including IN8bio, now in or nearing clinical trials for various cancers.
Drug Target Review
NOVEMBER 23, 2023
elegans be applied to the development of targeted therapies for neuropsychiatric conditions like eating disorders, OCD, and PTSD? He was a faculty member in the Biology Division at UCSD before moving to the MRC Laboratory of Molecular Biology in Cambridge, UK, in 2006, where he is currently a Group Leader.
Drug Target Review
JUNE 19, 2024
The mission of Lineage Cell Therapeutics is to deliver on some of the early promises of cell therapy. Cell therapy as a concept is a wonderful idea, but many of the early efforts never generated the kind of clinical data that gets people excited and leads to new medicines. In some cases, cell therapy can be curative for the patient.
Expert insights. Personalized for you.
96 
Let's personalize your content